Sciomics

Sciomics is at the forefront of biotechnology, dedicated to enhancing patient quality of life through advanced protein profiling and the utilization of molecular signatures for accurate diagnosis and treatment. Located at Karl-Landsteiner-Straße 6, Neckargemünd bei Heidelberg, Baden-Württemberg 69151, DE, Sciomics is deeply committed to driving the future of precision medicine by continually expanding its biomarker signature pipeline to address a wide range of clinical indications and advance precision diagnostics.

Sciomics' cutting-edge services empower scientists worldwide to unravel the complexities of disease, uncover modes of action, and identify promising protein biomarker candidates. The company's service portfolio is anchored in the state-of-the-art scioDiscover microarray platform for protein and post-translational modification profiling. Sciomics proudly supports a wide range of research, from basic scientific discovery to breakthrough pharmaceutical initiatives, offering a high-content, high-throughput system that provides fast and cost-effective solutions.

Sciomics' team is dedicated to supporting projects from planning to execution, navigating the most efficient route to achieve research objectives with unmatched proficiency in proteomic analysis. Sciomics provides customized solutions to meet specific research needs, delivering comprehensive data analysis and customized reports. Sciomics continues to revolutionize medicine through protein biomarker identification, novel drug target discovery, mode-of-action analysis, pathway activity analysis, and disease model characterization. We invite Sciomics' manager to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative contributions.